ATE245990T1 - Gemischter chimerismus und toleranz - Google Patents

Gemischter chimerismus und toleranz

Info

Publication number
ATE245990T1
ATE245990T1 AT00114769T AT00114769T ATE245990T1 AT E245990 T1 ATE245990 T1 AT E245990T1 AT 00114769 T AT00114769 T AT 00114769T AT 00114769 T AT00114769 T AT 00114769T AT E245990 T1 ATE245990 T1 AT E245990T1
Authority
AT
Austria
Prior art keywords
tolerance
mixed chimerism
chimerism
mixed
whole body
Prior art date
Application number
AT00114769T
Other languages
German (de)
English (en)
Inventor
Megan Sykes
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Application granted granted Critical
Publication of ATE245990T1 publication Critical patent/ATE245990T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Transplantation (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Gloves (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Heating, Cooling, Or Curing Plastics Or The Like In General (AREA)
AT00114769T 1996-05-09 1997-05-08 Gemischter chimerismus und toleranz ATE245990T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1709996P 1996-05-09 1996-05-09

Publications (1)

Publication Number Publication Date
ATE245990T1 true ATE245990T1 (de) 2003-08-15

Family

ID=21780711

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00114769T ATE245990T1 (de) 1996-05-09 1997-05-08 Gemischter chimerismus und toleranz

Country Status (9)

Country Link
US (4) US6006752A (en:Method)
EP (1) EP0918524A4 (en:Method)
JP (1) JP2000511888A (en:Method)
AT (1) ATE245990T1 (en:Method)
AU (1) AU734665B2 (en:Method)
CA (1) CA2253597A1 (en:Method)
DE (1) DE69723888T2 (en:Method)
ES (1) ES2201977T3 (en:Method)
WO (1) WO1997041863A1 (en:Method)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871728A (en) 1995-03-31 1999-02-16 University Of Pittsburgh Method of regulating dendritic cell maturation
CA2253597A1 (en) * 1996-05-09 1997-11-13 The General Hospital Corporation Mixed chimerism and tolerance
WO1999025367A2 (en) 1997-11-14 1999-05-27 The General Hospital Corporation Treatment of hematologic disorders
JP2002502823A (ja) 1998-02-04 2002-01-29 ザ・ジェネラル・ホスピタル・コーポレイション 移植における補刺激遮断および混合キメラ現象
CA2320040C (en) * 1998-03-18 2007-05-22 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
AU5575899A (en) * 1998-08-20 2000-03-14 Biotransplant Incorporated Inbred mhc-homozygous miniature swine and uses thereof
AU2980900A (en) * 1999-02-04 2000-08-25 General Hospital Corporation, The Methods for human allografting
AU3745900A (en) * 1999-03-15 2000-10-04 Modex Therapeutiques, S.A. Methods and compositions for tolerizing hosts for long term survival of tissue transplants
US6750023B2 (en) * 1999-09-02 2004-06-15 Corning Incorporated Porous inorganic substrate for high-density arrays
JP2003523323A (ja) * 1999-12-06 2003-08-05 ザ ジェネラル ホスピタル コーポレーション 膵臓幹細胞および移植におけるその使用
WO2001053825A1 (en) * 2000-01-19 2001-07-26 Biotransplant, Inc. Swine defective for transmission of porcine endogenous retrovirus and uses thereof
IL155728A0 (en) * 2000-11-22 2003-11-23 Geron Corp Tolerizing allografts of pluripotent stem cells
WO2002074938A1 (en) * 2001-03-20 2002-09-26 Trustees Of Amherst College Methods for producing antibodies in mammals
US20030044398A1 (en) * 2001-03-20 2003-03-06 Robl James M. Methods for producing antibodies in mammals
US20020152490A1 (en) * 2001-04-12 2002-10-17 Philip Lake Tolerance-inducing thy-marrow composite tissue construct and organ
US20030031652A1 (en) * 2001-04-16 2003-02-13 Bernhard Hering Systems and methods for inducing mixed chimerism
US20030032631A1 (en) * 2001-08-13 2003-02-13 Mcdonald George B. Method of treatment of cancer by controlling graft-versus-leukemia using topical active corticosteriods
US20050058641A1 (en) * 2002-05-22 2005-03-17 Siemionow Maria Z. Tolerance induction and maintenance in hematopoietic stem cell allografts
WO2003099330A1 (en) * 2002-05-22 2003-12-04 The Cleveland Clinic Foundation Induction and maintenance of tolerance to composite tissue allografts
US20050112122A1 (en) * 2003-09-02 2005-05-26 Greiner Dale L. Generation of hematopoietic chimerism and induction of central tolerance
US20050266001A1 (en) * 2004-04-02 2005-12-01 Hadley Gregg A Therapeutic blockade of CD103 interactions to prevent clinical renal allograft rejection
US20060147429A1 (en) * 2004-12-30 2006-07-06 Paul Diamond Facilitated cellular reconstitution of organs and tissues
US20060148080A1 (en) * 2004-12-30 2006-07-06 Paul Diamond Methods for supporting and producing human cells and tissues in non-human mammal hosts
US20070113297A1 (en) * 2005-09-13 2007-05-17 Yongguang Yang Methods and compositions for inhibition of immune responses
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
US8574567B2 (en) * 2007-05-03 2013-11-05 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
US20100291042A1 (en) 2007-05-03 2010-11-18 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
EP2841098A4 (en) 2012-04-23 2016-03-02 Allertein Therapeutics Llc NANOPARTICLES FOR THE TREATMENT OF ALLERGIES
AU2014221330B2 (en) 2013-02-26 2018-10-04 The Board Of Trustees Of The Leland Stanford Junior University Combined organ and hematopoietic cells for transplantation tolerance of grafts
MX375502B (es) 2013-04-03 2025-03-04 N Fold Llc Composiciones de nanoparticulas novedosas.
GB201413240D0 (en) * 2014-07-25 2014-09-10 Hansa Medical Ab Method
MX2019012567A (es) 2017-04-20 2020-02-13 Egenesis Inc Metodos para generar animales geneticamente modificados.
WO2019178106A1 (en) 2018-03-12 2019-09-19 Medeor Therapeutics, Inc. Methods for treating non-cancerous disorders using hematopoietic cells
US10842821B2 (en) 2018-04-05 2020-11-24 Medeor Therapeutics, Inc. Cellular compositions derived from prior organ donors and methods of manufacture and use thereof
US10881692B2 (en) 2018-04-05 2021-01-05 Medeor Therapeutics, Inc. Compositions for establishing mixed chimerism and methods of manufacture thereof
US11435350B2 (en) 2018-09-18 2022-09-06 Medeor Therapeutics, Inc. Methods of analysis of blood from deceased donors
US11813376B2 (en) 2018-09-18 2023-11-14 Medeor Therapeutics, Inc. Cellular compositions derived from deceased donors to promote graft tolerance and manufacture and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2126094A1 (en) * 1992-01-08 1993-07-22 David H. Sachs Induced tolerence to xenografts
US5658564A (en) * 1992-02-19 1997-08-19 The General Hospital Corporation Xenograft thymus
US5876708A (en) * 1992-02-19 1999-03-02 The General Hospital Corporation Allogeneic and xenogeneic transplantation
US5597563A (en) * 1992-09-04 1997-01-28 Beschorner; William E. Method induction of antigen-specific immune tolerance
IL107483A0 (en) * 1993-11-03 1994-02-27 Yeda Res & Dev Bone marrow transplantation
CA2253597A1 (en) 1996-05-09 1997-11-13 The General Hospital Corporation Mixed chimerism and tolerance
JP2002502823A (ja) * 1998-02-04 2002-01-29 ザ・ジェネラル・ホスピタル・コーポレイション 移植における補刺激遮断および混合キメラ現象

Also Published As

Publication number Publication date
US6877514B2 (en) 2005-04-12
US20030075187A1 (en) 2003-04-24
DE69723888T2 (de) 2004-05-27
ES2201977T3 (es) 2004-04-01
US6412492B1 (en) 2002-07-02
EP0918524A4 (en) 2000-11-08
WO1997041863A1 (en) 1997-11-13
DE69723888D1 (de) 2003-09-04
AU734665B2 (en) 2001-06-21
US20040247579A1 (en) 2004-12-09
CA2253597A1 (en) 1997-11-13
US6006752A (en) 1999-12-28
JP2000511888A (ja) 2000-09-12
EP0918524A1 (en) 1999-06-02
AU3120397A (en) 1997-11-26
US6718986B2 (en) 2004-04-13

Similar Documents

Publication Publication Date Title
ATE245990T1 (de) Gemischter chimerismus und toleranz
DE69739758D1 (de) Vakzine zur behandlung von lymphomen und leukämie
FR10C0016I1 (en:Method)
DE3670776D1 (de) System und zentrifugaloxygenator zur klaerung von abwasser.
DE3889245D1 (de) Integrierter und kontrollierter Leistungs-MOSFET.
DE3854540D1 (de) Behandlungsapparat und Verfahren.
DE69725961D1 (de) Befestigumgsvorrichtung und damit versehene prothese
NO891896L (no) Fremgangsmaate og innretning for behandling av medisinsk spesialavfall.
DE69734751D1 (de) Bestrahlungsbehandlungsvorrichtung und Verfahren
DE69731736D1 (de) Injektionsbehandlung zur beherrschung von muskelkrämpfen und damit einhergehenden schmerzen
FI953642A7 (fi) Jätevedenkäsittelymenetelmä ja -laite
PL330071A1 (en) Improved phototherapeutic methods and apparatus for irradiating columnar environments
DE69523888D1 (de) Feldemissionskathode und diese kathode verwendende vorrichtung
DE69303214D1 (de) Zusammensetzungen und Methoden zur Gaslochbehandlung
DE3851121D1 (de) Filamentlose Magnetron-Ionenquelle und Verwendungsverfahren.
DE69518099D1 (de) Leistungsverstärker und Verfahren dazu
MX9100051A (es) Mezcla esterilizante y metodo de esterilizacion
EE9600094A (et) Heitvee puhastusmeetod ja -seade
DE69729004D1 (de) Photodynamische therapie zur behandlung von osteosrthritis
FI951060A7 (fi) Formulaatioita ja hoitomenetelmiä
NO900696L (no) Fremgangsmaate og anordning for biologisk behandling omfattende nitrifisering og denitrifisering av avloepsvann.
DE69102215D1 (de) Realisierungsverfahren für Implantat-Prothese und hierbei verwendete Elemente.
BR9507859A (pt) Aparelho e método de registro flexivel de múltiplos subcanais
DE69522599D1 (de) Aufkohlungshärtungsverfahren und dadurch hergestellte Kraftübertragungselemente
NO985068L (no) Vaksiner for behandling av lymfom og leukemi

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties